Join reporter Barry Werth as he pulls back the drape on Vertex, a start-up pharmaceutical company, and witness firsthand the extreme drama being played out in the pioneering and hugely lucrative field of drug research study. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained clinical whiz kid, Vertex is dedicated to developing– atom by atom– both a new life-saving immunosuppressant drug, and a drug to fight the virus that triggers AIDS. You will be hooked from start to end up, as you go from the laboratories, where compulsive, increasingly competitive researchers battle for an advancement, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts financiers and finally decides to take Vertex public. Here is a remarkable no-holds-barred account of business of science, which includes an upgraded epilogue about the most recent developments in the mission for a drug to treat HELP.
No comments:
Post a Comment